✦ LIBER ✦

626 Pharmacokinetics and pharmacodynamics of valopicitabine (NM283), a new nucleoside HCV polymerase inhibitor: Results from a phase I/II dose-escalation trial in patients with HCV-1 infection

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

736 Early clearance of HCV RNA with valo

✍ D. Dieterich; E. Lawitz; T. Nguyen; Z. Younes; J. Santoro; N. Gitlin; D. McEniry 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 248 KB

1046 FIRST-IN-MAN DEMONSTRATION OF POTEN

✍ Gane, E.J.; Roberts, S.K.; Stedman, C.; Angus, P.W.; Ritchie, B.; Elston, R.; Ip 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB